Government Insurers Balk At Paying For CAR-T Cancer Drug

July 17, 2018 | Treatment costs for the immunotherapy can run to more than $1 million. Some state Medicaid programs aren't paying for the treatment, and Medicare's complicated payment rates have hospitals worried. NPR